For the year ending 2025-12-31, NTLA had -$35,219K decrease in cash & cash equivalents over the period. -$395,865K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Collaboration revenue | 67,671 |
| Research and development | 388,861 |
| General and administrative | 119,800 |
| Interest income | 29,195 |
| Loss from equity method investment | 0 |
| Other (income) expense, net | -899 |
| Net loss | -412,694 |
| Depreciation and amortization | 9,767 |
| Loss (gain) on disposal of property and equipment | -527 |
| Accelerated amortization/impairment of right-of-use assets | 6,156 |
| Stock-based compensation | 80,219 |
| Accretion of investment discounts and premiums | 5,858 |
| Change in fair value of investments, net | -899 |
| (recognition) deferral of equity method investment intra-entity profit on sales | 0 |
| Loss from equity method investment | 0 |
| Change in fair value of contingent consideration | 0 |
| Accounts receivable | 951 |
| Prepaid expenses and other current assets | 26,352 |
| Operating lease right-of-use assets | -33,086 |
| Other assets | -2,811 |
| Accounts payable | 5,987 |
| Accrued expenses | -5,271 |
| Deferred revenue | -28,111 |
| Operating lease liabilities | -54,951 |
| Net cash used in operating activities | -394,736 |
| Purchases of property and equipment | 1,129 |
| Purchases of marketable securities | 322,510 |
| Sales and maturities of marketable securities | 551,670 |
| Net cash provided by (used in) investing activities | 228,031 |
| Net proceeds from issuance of common stock | 128,175 |
| Proceeds from options exercised | 722 |
| Issuance of shares through employee stock purchase plan | 2,589 |
| Net cash provided by financing activities | 131,486 |
| Net (decrease) increase in cash, cash equivalents and restricted cash equivalents | -35,219 |
| Cash, cash equivalents and restricted cash equivalents, beginning of period | 202,787 |
| Cash, cash equivalents and restricted cash equivalents, end of period | 167,568 |
Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA)